Adiponectin in Asthma and Obesity: Protective Agent or Risk Factor for More Severe Disease?

Lung

Volumn 193, Issue 5, 2015, Pages 749-755

  de Lima Azambuja, Renato ^a   da Costa Santos Azambuja, Layla Salomao Eulalio ^a   Costa, Cláudia ^a   Rufino, Rogério ^a,b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

Adiponectin; Asthma; Interleukin 33; Obesity; TH2 inflammation

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 33;

ADULT; ARTICLE; ASTHMA; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; AGED; BLOOD; COMPLICATION; IDEAL BODY WEIGHT; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTECTION; RANDOMIZATION; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADIPONECTIN; ADULT; AGED; ASTHMA; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IDEAL BODY WEIGHT; INFLAMMATION; INTERLEUKIN-33; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROTECTIVE FACTORS; RANDOM ALLOCATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84942550465     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-015-9793-8     Document Type: Article

References (34)

1. Shore SA, Johnston RA (2006) Obesity and asthma. Pharmacol Ther 110:83–203
2. Ford ES (2005) The epidemiology of obesity and asthma. J Allergy Clin Immunol 115:897–909
3. Delgado J, Barranco P, Quirce S (2008) Obesity and asthma. J Investig Allergol Clin Immunol 18:420–425
4. Camilo DF, Ribeiro JD, Toro ADCT, Baracat ECE, Barros Filho AA (2010) Obesidade e asma: associação ou coincidência? J Pediatr (Rio J) 86:6–14
5. Liu MC, Hubbard WC, Proud D, Stealey BA, Galli SJ, Kagey-Sobotka A, Bleecker ER, Lichtenstein LM (1991) Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis 144:51–58
6. Patel PS, Buras ED, Balasubramanyam A (2013) The role of the immune system in obesity and insulin resistance. J Obes 2013:616193
7. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91
8. Trayhurn P, Wood IS (2005) Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33:1078–1081
9. Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, Goldberg R (2006) C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract 71:92–100
10. Miller AM (2011) Role of IL-33 in inflammation and disease. J Inflamm (Lond) 8:22
11. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479–490
12. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, Nambu A, Abe T, Kiyonari H, Matsumoto K, Sudo K, Okumura K, Saito H, Nakae S (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Prac Natl Acad Sci USA 107:18581–18586
13. Miller AM, Asquith DL, Hueber AJ, Anderson LA, Holmes WM, McKenzie AN, Xu D, Sattar N, McInnes IB, Liew FY (2010) Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res 107:650–658
14. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83
15. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968
16. Xu A, Wang Y, Keshaw H, Xu LY, Lam KSL, Cooper GJS (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. doi:10.1172/JCI200317797
17. Spanevello A, Confalonieri M, Sulotto F, Romano F, Balzano G, Migliori GB, Bianchi A, Michetti G (2000) Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 162:1172–1174
18. Global initiative for asthma (2014) Global strategy for asthma management and prevention. http://www.ginasthma.org. Accessed 06 June 2015
19. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35
20. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273–2282
21. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, Yoshimatsu H (2004) Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 40:177–184
22. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, Maeda K, Nagaretani H, Kishida K, Maeda N, Nagasawa A, Funahashi T, Matsuzawa Y (2004) Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109:2046–2049
23. Wolff B, Cieza A, Parentin A, Rauch A, Sigl T, Brockow T, Stucki A (2004) Identifying the concepts contained in outcome measures of clinical trials on four internal disorders using the International Classification of Functioning, Disability and Health as a reference. J Rehabil Med 44(Suppl):37–42
24. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME (2004) Adiponectin differentially regultes cytocines in porcine macrophages. Biochem Biophys Res Commun 316:37–42
25. Shore SA, Terry RD, Flynt L, Xu A, Hug C (2006) Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 118:389–395
26. Medoff BD, Okamoto Y, Leyton P, Weng M, Sandall BP, Raher MJ, Kihara S, Bloch KD, Libby P, Luster AD (2009) Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol 41:397–406
27. Lugogo NL, Bappanad D, Kraft M (2011) Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim Biophys Acta 1810:1120–1126
28. Sood A, Cui X, Qualls C, Beckett WS, Gross MD, Steffes MW, Smith LJ, Jacobs DR (2008) Association between asthma and serum adiponectin concentration in women. Thorax 63:877–882
29. Sood A, Qualls C, Schuyler M, Thyagarajan B, Steffes MW, Smith LJ, Jacobs DR (2012) Low serum Adiponectin predicts future risk for asthma in women. Am J Respir Crit Care Med 186:41–47
30. Sood A, Dominic E, Qualls C, Steffes MW, Thyagarajan B, Smith LJ, Lewis CE, Jacobs DR (2011) Serum adiponectin is associated with adverse outcomes of asthma in men but not in women. Front Pharmacol 2:1–11
31. Salome CM, King GG, Berend N (2010) Physiology of obesity and effects on lung function. J Appl Physiol (1985) 108:206–211
32. Ghabashi AE, Iqbal M (2006) Obesity and its correlation with spirometric variables in patients with asthma. MedGenMed 8:58
33. Lécart S, Lecointe N, Subramaniam A, Alkan S, Ni D, Chen R, Boulay V, Pène J, Kuroiwa K, Tominaga S, Yssel H (2002) Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. Eur J Immunol 32:2979–2987
34. Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel “alarmin”? PLoS ONE 3:e3331